Code of Massachusetts Regulations
247 CMR - BOARD OF REGISTRATION IN PHARMACY
Title 247 CMR 6.00 - Registration, Management And Operation Of A Pharmacy Or Pharmacy Department
Section 6.14 - Duty to Report Certain Improper Drug Dispensing to the Board
Current through Register 1531, September 27, 2024
Effective January 1, 2010, a pharmacy licensed by the Board is required to report to the Board any improper dispensing of a prescription drug that results in serious injury or death, as defined by the Board, as soon as is reasonably and practicably possible but not later than 15 business days after discovery or being informed of such improper dispensing. The duty to report to the Board any improper dispensing of a prescription drug that results in serious injury or death, pursuant to M.G.L. c. 112, § 39D and 247 CMR 6.14(2), shall be in addition to the Continuous Quality Improvement (CQI) Program requirements of 247 CMR 15.00. Only those events of improper dispensing of a prescription drug that result in serious injury or death are required to be reported to the Board, in accordance with M.G.L. c. 112, § 39D and 247 CMR 6.14(2).
(1) Definitions. For purposes of reporting to the Board, as required by M.G.L. c. 112, § 39D:
(2) Reporting Responsibility. Effective January 1, 2010, a pharmacy shall file a report with the Board of the improper dispensing of a prescription drug that results in serious injury or death, on a form to be provided by the Board, within 15 business days of the pharmacy discovering or being informed of such improper dispensing. A pharmacy shall provide all records relating to such improper dispensing to the Board upon request.
(3) Records Retention. The pharmacy shall retain all records relating to the improper dispensing of a prescription drug that results in serious injury or death which is required to be reported to the Board, in accordance with the requirements of M.G.L. c. 112, § 39D and 247 CMR 6.14(2), for a minimum period of two years from the date the report is filed with the Board.